Molecular typing of antibiotic-resistant Staphylococcus aureus in Nigeria  by O’Malley, S.M. et al.
JM
S
S
A
R
a
I
b
c
d
e
f
C
R
h
1ournal of Infection and Public Health (2015) 8, 187—193
olecular  typing  of  antibiotic-resistant
taphylococcus  aureus  in  Nigeria
.M.  O’Malleya,  F.E.  Emeleb,  F.O.  Nwaokoriec,  N.  Idikac,
.K.  Umeizudiked,  I.  Emeka-Nwabunniae,  B.M.  Hansona,
.  Naira,  S.E.  Wardyna,  T.C.  Smith f,∗
Center  for  Emerging  Infectious  Diseases,  College  of  Public  Health,  University  of
owa, United  States
Department  of  Medical  Microbiology,  Nnamdi  Azikiwe  University,  Nigeria
Nigerian  Institute  of  Medical  Research,  Nigeria
Lagos  University  Teaching  Hospital,  Nigeria
Department  of  Biotechnology,  Federal  University  of  Technology,  Owerri,  Nigeria
Department  of  Biostatistics,  Environmental  Health  Sciences,  &  Epidemiology,
ollege of  Public  Health,  Kent  State  University,  United  States
eceived  24  May  2014;  received  in  revised  form  29  July  2014;  accepted  24  August  2014
KEYWORDS
Antibiotic  resistance;
Staphylococcus  aureus;
Nigeria;
Epidemiology;
spa  typing;
PVL;
mecA
Summary
Background:  Antibiotic-resistant  Staphylococcus  aureus  including  methicillin-
resistant  strains  (MRSA)  are  a  major  concern  in  densely  populated  urban  areas.  Initial
studies  of  S.  aureus  in  Nigeria  indicated  existence  of  antibiotic-resistant  S.  aureus
strains  in  clinical  and  community  settings.
Methods:  73  biological  samples  (40  throat,  23  nasal,  10  wound)  were  collected
from  patients  and  healthcare  workers  in  three  populations  in  Nigeria:  Lagos  Univer-
sity  Teaching  Hospital,  Nigerian  Institute  of  Medical  Research,  and  Owerri  General
Hospital.
Results:  S.  aureus  was  isolated  from  38  of  73  samples  (52%).  Of  the  38  S.  aureus
samples,  9  (24%)  carried  the  Panton-Valentine  leukocidin  gene  (PVL)  while  16  (42%)
possessed  methicillin  resistance  genes  (mecA).  Antibiotic  susceptibility  proﬁles  indi-
cated  resistance  to  several  broad-spectrum  antibiotics.
Conclusion:  Antibiotic-resistant  S.  aureus  isolates  were  recovered  from  clinical  and
community  settings  in  Nigeria.  Insight  about  S.  aureus  in  Nigeria  may  be  used  to
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cription  methods  and  minimize  the  spread  of  antibiotic-
ghly  populated  urban  communities  similar  to  Lagos,  Nigeria.
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swab was  suspended  in  sterile  6.5%  Nutrient  Broth
No. 2  (NB),  in  tubes,  and  incubated  at  37 ◦C  for
24 h  [11]. Ten  microliters  was  transferred  from188  
improve  antibiotic  pres
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Introduction
Staphylococcus  aureus  (S.  aureus)  is  a gram-
positive bacterium  that  exists  in  clinical  and
community settings  across  the  world  [1—3].  Recent
estimates  suggest  approximately  30%  of  humans  are
asymptomatic  carriers  of  S.  aureus  in  their  nares
and/or  throat  [4]. Carriers  of  S.  aureus  are  between
three to  six  times  more  likely  to  suffer  from  a
clinical S.  aureus  infection  than  non-carriers  [4,5].
Furthermore,  about  80%  of  invasive  S.  aureus  infec-
tions originate  from  a  strain  occurring  in  the  host’s
natural microﬂora  [3,4].  Clinical  infections  of  S.
aureus can  range  from  mild  to  severe,  leading  to
various  diseases  such  as  skin  and  deep  tissue  infec-
tions, pneumonia,  and  osteomyelitis  [4].
In hospital  settings,  antibiotic-resistant  S.
aureus is  a  common  etiological  agent  of  healthcare-
associated infections  (HAIs)  [6]. Highly  virulent
antibiotic-resistant  S.  aureus  in  these  settings
is of  particular  concern,  including  methicillin-
resistant strains.  In the  United  States  alone,
approximately  95,000  invasive  methicillin-resistant
S. aureus  (MRSA)  infections  occur  each  year  [5].
The mecA  gene  found  in  methicillin-resistant  S.
aureus organisms  confers  resistance  against  a host
of antibiotics  including  methicillin  and  oxacillin;
this genetic  property  may  cause  these  organisms
to exhibit  resistant  to  other  antibiotics  including
tetracyclines, penicillins,  and  carbapenems.  The
PVL genes  encode  the  Panton-Valentine  leukocidin,
a putative  virulence  factor,  which  is  hypothesized
to enhance  the  bacterium’s  ability  to  cause  severe
infections  in  human  and  animal  hosts  [7,8].
Healthcare-associated  (HAI)  and  community-
associated (CA)  S.  aureus  are  major  global  health
problems,  yet  little  is known  about  their  impact
in Nigeria.  Nigeria  is  the  most  populous  country  in
Africa and  boasts  the  second  most  populous  city
in Africa,  Lagos,  which  has  a  population  over  13
million people  [9].  Due  to  a  high  population  den-
sity (approximately  7000  people  per  square  mile)
[10],  sufﬁcient  medical  attention  is  often  not  avail-
able to  all  patients  and  signiﬁcant  public  health
problems are  often  poorly  understood.  Speciﬁcally,
antibiotic resistance  proﬁles  of  S.  aureus  isolates
may  be  conferred  from  wide  spread  misuse  of
these  antibiotics.  In  a  prior  study  of  S. aureus  in
Nigeria, 68  S.  aureus  samples  were  collected  in
e
m
f
oarious  health  institutions  throughout  the  country
1]. Eleven  isolates  (11/68,  16%)  were  identiﬁed
s MRSA.  Remaining  isolates  showed  resistance  to
uch antibiotics  as  erythromycin,  tetracycline,  and
MP/SMX.
Researchers  from  the  Center  for  Emerging  Infec-
ious Diseases  (CEID)  at  the  University  of  Iowa  col-
aborated  with  researchers  at  the  Nigerian  Institute
f Medical  Research  in  Lagos,  Nigeria.  The  objective
f the  research  was  to  identify  molecular  types  of
ntibiotic-resistant  S.  aureus  within  community  and
linical settings  in  Lagos  and  Owerri,  Nigeria.
ethods/materials
ifty-eight  nasal  or  throat  samples  were  collected
rom patients,  healthcare  workers,  or  volun-
eers at  Lagos  University  Teaching  Hospital  Dental
linic (LUTH-DC)  and  Nigerian  Institute  of  Med-
cal Research  HIV  Clinic  Yaba,  Lagos  (NIMR-HC).
asal and  throat  samples  were  collected  from  HIV
ositive volunteers,  and  from  other  NIMR  Volun-
eers,  while  throat  samples  were  collected  from
atients  and  healthcare  workers  at  the  LUTH-DC.
n total,  58  biological  samples  were  collected  from
7 participants  in  June  and  July  2012.  Institu-
ional Review  Board  approval  was  obtained  through
he University  of  Iowa  in  Iowa  City,  USA,  Nigerian
nstitute of  Medical  Research  Yaba,  Lagos,  Nigeria,
nd Dr.  Adesola  Kehinde  Umeizudike,  Department
f Preventive  Dentistry,  Lagos  University  Teach-
ng Hospital  (LUTH,  Idi-Araba)  in  Lagos,  Nigeria.
nformed  consent  was  obtained  from  participants  in
agos, Nigeria.  Additionally,  ﬁfteen  S.  aureus  stock
solates from  Owerri  General  Hospital  in  Owerri,
igeria (eight  wound  and  ﬁve  throat  samples)  and
agos University  Teaching  Hospital  in  Lagos,  Nigeria
two wound  isolates)  were  included  with  the  col-
ected samples  for  molecular  analysis  (Table  1).
The nose  and  throat  samples  were  collected
sing sterile  cotton  swabs.  Once  collected,  eachach incubated  tube  to  plate  of  Staphylococcus
edium No.  110  (SM)  and  allowed  to  grow  at  37 ◦C
or 48  h [12]. After  incubation,  samples  displaying
range, circular  colonies  on  SM  were  sub-cultured
S.  aureus  in  Nigeria  
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n  Mueller  Hinton  Agar  (MHA)  and  incubated  for
nother  24  h.  Presumptive  S.  aureus  isolates  were
onﬁrmed  by  Gram  stain,  catalase  test,  and  coag-
lase test.  Positive  isolates  were  shipped  to  the
enter  for  Emerging  Infectious  Diseases  (CEID)  for
dditional diagnostic  conﬁrmation  and  molecular
esting  [13].
Positive  S.  aureus  isolates  were  subject  to  poly-
erase  chain  reaction  (PCR)  for  S.  aureus  protein
 (spa)  using  primers  described  by  Ridom  GmbH
Würzburg,  Germany,  2004;  http://www.ridom.de/
oc/Ridom spa sequencing.pdf), methicillin  resis-
ance (mecA)  gene,  and  presence  of  PVL  gene
14,15]. Isolates  with  antibiotic-resistant  genes,
r a  common  spa  type,  underwent  multilo-
us sequence  typing  (MLST)  [16].  Lastly,  pre-
umptive S.  aureus  isolates  were  subjected  to
ntibiotic  susceptibility  testing  by  broth  microdi-
ution technique,  deﬁned  by  Weigand  and  col-
eagues [17],  using  the  following  antibiotics:
xacillin, tetracycline,  erythromycin,  clindamycin,
rimethoprim—sulfamethoxazole  (TMP/SMX),  gen-
amycin,  levoﬂoxacin,  vancomycin,  daptomycin,
uinupristin/dalfopristin,  linezolid,  and  rifampin.
. aureus  isolates  were  stored  in  glycerol  solution
t −80 ◦C,  until  needed  [13].
esults
verall,  73  samples  (40  throat,  23  nasal,  10  wound)
ere analyzed  as  part  of  the  study;  58  samples  were
ollected  from  participants  in  Lagos,  Nigeria  while
he remaining  13  samples  included  previously  col-
ected stock  isolates  from  participants  in  Lagos  and
werri, Nigeria.  S.  aureus  was  isolated  from  38  of
3 samples  (52%;  95%  CI  40.6%—63.5%).
The overall  prevalence  of  S.  aureus  coloniza-
ion among  healthcare  workers  and  patients  was
2% (30/58;  95%  CI  38.9%—64.6%).  The  addi-
ional ﬁfteen  stock  isolates  from  Owerri  General
ospital (8  wound  samples  and  5  throat  sam-
les) and  Lagos  University  Teaching  Hospital  (2
ound samples)  were  included  in  molecular  anal-
sis but  not  as  part  of  colonization  rates  because
hey were  collected  and  identiﬁed  as  S. aureus
solates in  a  previous  study.  Fifty  percent  of  sam-
les (6/12;  95%  CI  21.7%—78.3%)  collected  from
agos University  Teaching  Hospital  Dental  Clinic
ere conﬁrmed  S.  aureus,  54%  (14/26;  95%  CI
4.5%—73.0%)  from  Nigerian  Institute  of  Medical
esearch (NIMR)  HIV  volunteers  were  conﬁrmed  S.
ureus, and  50%  (10/20;  95%  CI  28.1%—71.9%)  from
ther NIMR  Volunteers  were  conﬁrmed  S.  aureus.
n total,  19%  of  colonization  samples  (11/58;  95%
I 8.9%—29.1%)  and  22%  of  all  samples,  including
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colonization  samples  and  stock  isolates  (16/73;  95%
CI 12.4%—31.4%),  were  mecA  positive.
Antibiotic susceptibility testing
Antibiotic  susceptibility  testing  was  carried  out
on the  38  S.  aureus  isolates.  Thirty-two  (84%;
95% CI  72.6%—95.8%)  were  resistant  to  tetra-
cycline, 29  (76%;  95%  CI  62.8%—89.8%)  were
resistant to  TMP/SMX,  7  (18%;  95%  CI  6.1%—30.7%)
were resistant  to  levoﬂoxacin,  5 (13%;  95%  CI
2.4%—23.9%) were  resistant  to  gentamycin,  and
5 (13%;  95%  CI  2.4%—23.9%)  were  resistant  to
erythromycin. All  isolates  were  susceptible  to
clindamycin,  vancomycin,  daptomycin,  Q/D,  line-
zolid, and  rifampin.  Furthermore,  16  (42%;  95%  CI
26.4%—57.8%)  of  isolates  were  found  to  be  pheno-
typically methicillin-resistant—–only  one  S.  aureus
isolate with  the  mecA  gene  (1/16)  was  susceptible
to oxacillin.  Only  one  oxacillin-resistant  S.  aureus
isolate  did  not  possess  the  mecA  gene.
Molecular analysis
PCR  was  conducted  on  presumptive  S.  aureus  iso-
lates to  conﬁrm  spa,  mecA,  and  PVL  status.  Thirteen
distinct spa  types  were  identiﬁed  among  the  38  S.
aureus isolates  taken  from  wound,  throat,  or  nasal
sites. The  spa  types  common  to  more  than  one  indi-
vidual were  t064  (11/38,  29%;  95%  CI  14.5%—43.4%),
t355 (10/38,  26%;  95%  CI  12.3%—40.3%),  t084,
t091, and  t657  which  accounted  for  three  isolates
apiece,  or  8%  of  all  isolates,  respectively.  PVL-
encoding  genes  were  identiﬁed  in  24%  (9/38;  95%  CI
10.2%—37.2%)  of  known  S.  aureus  isolates,  with  all
but one  found  in  methicillin-susceptible  S.  aureus
(MSSA);  all  nine  isolates  carrying  the  PVL  genes
were spa  type  t355.
Multilocus sequence typing
Multilocus  sequence  typing  (MLST)  was  performed
on eight  S.  aureus  isolates,  six  of  which  had  the
mecA gene—–ﬁve  isolates  were  ST8  (spa  types  t064,
t5604,  t11754)  and  one  of  each  was  ST152  (spa  type
t355), ST772  (spa  type  t657),  ST14  (spa  type  t084).
Discussion
Based  on  results  of  this  study,  we  have  reasons  to
suggest  that  antibiotic-resistant  S.  aureus,  specif-
ically methicillin-resistant  strains,  and  potentially
virulent  S.  aureus  strains  exist  in  clinical  and
community  settings  in  Nigeria.  In  agreement  with
previous  studies,  we  found  t064/ST8  as  the  most
p
c
tS.M.  O’Malley  et  al.
ommon  spa  type  among  the  study  population.  Fur-
hermore, researchers  are  of  the  view  that  t064
s the  most  common  spa  type  among  HIV-positive
atients in  Nigeria  [18].  Similarly,  t064  was  the  most
requent  spa  type  among  participants  in  our  study
11/38, 29%)  including  44%  (4/9)  of  HIV-positive
articipants exhibiting  nose  or  throat  colonization,
ften times  in  both  sites.  Shittu  and  colleagues  [1]
rimarily  collected  wound  samples  from  individ-
als suffering  from  a clinical  S.  aureus  infection
hereas our  samples  were  primarily  collected
rom nose  and  throat  sites  of  clinically  healthy
ndividuals with  additional  analysis  of  S.  aureus
ound isolates  from  a recent  study.  Still,  similar
pa types  (e.g.  t064,  t355)  were  found  in  both
pidemiologic studies  suggesting  that  colonized
ndividuals may  facilitate  transmission,  especially
mong  immune-compromised  individuals.  Conduct-
ng a  longitudinal  epidemiologic  study  among  these
opulations  would  be  useful  to  determine  if nasal
nd throat  colonization  is  transient  and  whether
r not  individuals  colonized  with  S.  aureus  can  be
nfected with  those  same  organisms.
Sequence type  (ST)  8  (e.g.  spa  type  t064,
A-MRSA) has  been  documented  to  cause  severe
nfections in  humans  and  can  be  found  within  ani-
als and  humans  in  Europe,  Asia,  and  the  Americas,
s well  as  Africa  [5,18—21]. ST8  (spa  type  t064)
ith mecA  gene  was  isolated  from  participants  in
ll three  populations  that  we  sampled  and  repre-
ented  two  distinct  geographical  regions  of  Nigeria
hich  are  separated  by  more  than  300  miles.  Fur-
hermore,  ST8  was  isolated  from  nose,  throat,  and
ound sites  and  from  both  HIV-positive  and  non
IV-positive  individuals.  These  results  tend  to  sug-
est that  antibiotic-resistant  S.  aureus,  speciﬁcally
T8, is  ubiquitous  in  various  geographic  regions  of
igeria.
Our results  also  showed  that  30  individuals  (52%)
ere positive  for  S. aureus  colonization  in  either
heir nose  or  throat  (Table  2). Still,  we  are  aware
hat because  our  study  population  includes  both
IV-positive  and  non  HIV-positive  individuals,  it
ay be  difﬁcult  to  draw  conclusions  about  S.
ureus colonization  rates  among  the  general  pop-
lation in  Nigeria.  Evidence  suggests  S.  aureus
olonization rates  and  MRSA  clinical  infections
ay be  markedly  different  between  HIV-positive
opulations and  HIV-negative  populations  [22—24].
esearchers [18]  found  that  33%  of  HIV-positive  par-
icipants (124/375)  were  colonized  with  S.  aureus,
wenty  of  whom  were  colonized  with  MRSA,  com-
ared to  21%  of  HIV-negative  participants  (78/370)
olonized  with  S.  aureus.
In our  study,  69%  of  individuals  (9/13)  from
he NIMR  HIV  clinic  were  colonized  with  S.  aureus
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Table  2  Molecular  epidemiology  of  S.  aureus  from  30  participants.
ID  Participant  Population  Site  spa  type  PVL  mecA  MLST  Resistance  proﬁle
1  HCW  A  T  t084  −  −  NT  Tet
2  Patient  A  T  t084  −  −  NT  None
3  HCW  A  T  t127  −  −  NT  Tet
4  Patient  A  T  t084  −  −  NT  O,  Tet,  TMP
5  HCW  A  T  t064  −  +  ST8  O,  Tet,  TMP
6  HCW  A  T  t385  −  −  NT  Tet
7a  Patient B  N  t657  −  +  NT  O,  E,  TMP,  G,  L
7b  Patient B  T  t657  −  +  NT  O,  E,  TMP,  G,  L
8  Patient  B  N  t064  −  +  NT  O,  Tet,  TMP
9a  Patient  B  N  t064  −  −  NT  Tet,  TMP
9b  Patient  B  T  t657  −  +  ST772  O,  E,  TMP,  G,  L
10  Patient  B  N  t064  −  +  NT  O,  Tet,  TMP
11  Patient  B  T  t064  −  +  ST8  O,  Tet,  TMP
12a  Patient  B  N  t355  +  −  NT  Tet,  TMP
12b  Patient  B  T  t355  +  −  NT  Tet,  TMP
13a  Patient  B  N  t355  +  −  NT  Tet,  TMP
13b  Patient  B  T  t355  +  −  NT  Tet,  TMP
14a  Patient  B  N  t064  −  +  NT  O,  Tet,  TMP
14b  Patient  B  T  t355  +  −  NT  Tet,  TMP
15  Patient  B  N  t355  +  +  ST152  Tet,  TMP
16  Volunteer C  N  t064  −  +  ST8  O,  Tet,  TMP
17a  Volunteer  C  N  t355  +  −  NT  Tet,  TMP
17b  Volunteer C  T  t2078  −  −  NT  None
18  Volunteer C  N  t355  +  −  NT  Tet,  TMP
19  Volunteer C  T  t064  −  +  NT  O,  Tet,  TMP
20  Volunteer C  N  t355  +  −  NT  Tet,  TMP
21a  Volunteer C  N  t091  −  −  NT  Tet,  TMP,  L
21b  Volunteer C  T  t091  −  −  NT  Tet,  L
22a  Volunteer C  N  t5064  −  −  NT  Tet,  L
22b  Volunteer  C  T  t2216  −  −  NT  Tet
23  Patient  D  T  t1452  −  −  NT  Tet,  E,  TMP
24  Patient  D  T  t064  −  +  NT  O,  Tet,  TMP,  G
25  Patient  D  W  t5604  −  +  ST8  O,  Tet,  TMP
26  Patient  D  W  t11754  −  −  ST8  Tet,  E,  TMP,  G,  L
27  Patient  D  W  t064  −  +  NT  O,  Tet,  TMP
28  Patient  D  W  t064  −  +  NT  O,  Tet,  TMP
29  Patient  D  W  t159  −  −  NT  TMP
30  Patient  D  W  t064  −  +  NT  O,  Tet,  TMP
Note—–Participant type: HCW = healthcare worker; population: A = dental clinic, B = HIV clinic, C = NIMR volunteers, D = Owerri
hospital; Site: N = nose, T = throat, W = wound; MLST: NT = not tested; resistance proﬁle: O = oxacillin, Tet = tetracycline,
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tE = erythromycin, TMP-SMX = TMP, G = gentamycin, L = levoﬂoxa
ith  ﬁve  of  the  nine  individuals  colonized  in
oth nose  and  throat.  It  seems  that  immunode-
ciency facilitates  antibiotic-resistant  S.  aureus
ransmission,  since  our  ﬁndings  and  those  from
ther  researchers  [1,18,22—24]  indicate  higher  col-
nization  and  infection  rates  of  S.  aureus  among
IV-positive individuals,  compared  to  their  healthy
ounterparts.  HIV  clinics  are  often  crowded,  which
ay facilitate  transmission  between  individuals.  Ithould be  pointed  out  that  HIV-positive  individ-
als who  are  colonized  with  S.  aureus  may  be  at
ncreased  risk  of  developing  an  infection  in  the  com-
unity or  hospital.  Additional  investigation  should
t
n
s
ze  conducted  to  determine  S.  aureus  colonization
nd infection  rates  among  HIV-positive  individuals
nd non  HIV-positive  individuals  in  various  clinical
ettings.
Antibiotic  resistance  proﬁles  of  the  isolates
ollected for  this  study  are  consistent  with  ear-
ier studies  investigating  S.  aureus  in  Nigeria  [1].
e found  antibiotic-susceptibility  proﬁles  similar
o other  researchers  in  Nigeria  including  resis-
ance to  oxacillin,  tetracycline,  and  TMP/SMX;
one of  the  tested  S.  aureus  isolates  in  this
tudy exhibited  resistance  to  vancomycin,  line-
olid, daptomycin,  or  rifampin.  Tetracycline  and
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TMP/SMX  are  among  the  most  commonly  used
antibiotics in  Nigeria  because  these  antibiotics  are
cheap and  easily  obtainable  through  lenient  med-
ication  regulations.  Conversely,  more  expensive
and less  frequently  used  antibiotics  like  line-
zolid and  vancomycin  were  not  readily  resisted.
Based on  both  ﬁndings,  it  could  be  concluded  that
antibiotic  over-prescription  and  misuse,  speciﬁcally
widespread  distribution  of  broad-spectrum  antibi-
otics (tetracycline  and  TMP/SMX),  may  elevate
antibiotic-resistant  S.  aureus  nasal  and  pharynx
carriage, transmission,  and  subsequent  infection,
especially  in  urban  populations  of  Nigeria.
Regarding  virulence  factors,  previous  ﬁndings
indicated 40%  (23/57)  of  methicillin-susceptible
S. aureus  (MSSA)  isolates  were  PVL-positive;  no
PVL-positive  MRSA  was  reported  in  the  study  [1].
In agreement  with  their  report,  we  found  PVL-
positive isolates  most  often  in  MSSA.  A  single
PVL-positive MRSA  organism  was  isolated  in  our
study,  suggesting  that  PVL-encoding  genes  exist
in antibiotic-resistant  organisms  in  Nigeria.  These
antibiotic-resistant  and  potentially  virulent  orga-
nisms may  cause  more  severe  infections  in  humans
and  survive  through  antibiotic  treatment.
Intervention  strategies  to  reduce  S.  aureus
carriage in  the  healthcare  setting  have  been  well-
studied.  For  example,  a  report  written  by  Friedel
and Climo  [25]  indicated  topical  intranasal  antimi-
crobials  such  as  Mupirocin  are  effective  in  reducing
S. aureus  nasal  carriage  but  have  been  associated
with antimicrobial  resistance  and  may  be  inef-
fective for  long-term  decolonization  of  S.  aureus.
Adesida  and  colleagues  [26]  suggest  S.  aureus
colonization rates  among  medical  students  at a  ter-
tiary medical  center  in  Lagos,  Nigeria  are  heavily
inﬂuenced by  personal  behaviors.  They  concluded
adhering to  personal  hygiene  behaviors  including
handwashing will  likely  decrease  colonization  rates
among healthcare  personnel  and  could  be  effective
as a  primary  infection  control  measure  in  Nigeria
[26].  Still,  the  key  to  a  successful  infection  control
intervention  is  addressing  a  combination  of  hand
hygiene  determinants  at  the  individual,  interper-
sonal, and  institutional  levels  [27].
It is  pertinent  to  point  out  that  the  present  study
suffers  some  limitations.  First,  the  sample  size  was
small with  only  73  samples,  58  of  which  were  col-
lected  from  participants  as  part  of  this  study.  As  a
result, we  are  careful  not  to  conclude  that  S.  aureus
colonization  rates  from  our  sample  collection  are
indicative  of  the  true  colonization  rate  of  residents
in Lagos,  Nigeria.  Furthermore,  our  samples  were
collected  conveniently,  which  may  suggest  that  the
samples may  not  be  representative  of  the  entire
population of  Lagos,  Nigeria.  The  samples  were
R
o
I
aS.M.  O’Malley  et  al.
ollected  from  patients  and  healthcare  workers
ho were  readily  available  and  willing  to  partici-
ate in  the  study  because  there  was  a short  time
rame on  site  in  Lagos  to  collect  and  analyze  each
ample.  Also,  study  participants  were  from  the
igerian  Institute  of  Medical  Research  and  Lagos
niversity  Teaching  Hospital  located  less  than  two
iles apart.  Consequently,  S.  aureus  colonization
ates and  spa  types  found  in  this  study  may  not  be
eﬂective  of  the  situation  in  other  parts  of  Lagos,
igeria.
Still,  there  were  advantages  to  this  observa-
ional study.  For  instance,  we  conducted  extensive
olecular  typing  on  collected  isolates.  PCR  was
erformed  to  identify  spa,  mecA,  and  PVL  genes
or all  S.  aureus  isolates.  Also,  each  presumptive  S.
ureus isolate  was  tested  for  susceptibility  against
 wide  range  of  antibiotics  used  in  Nigeria  so  we
an be  certain  that  S.  aureus  isolates  in  this  study
xhibit  genotypic  and  phenotypic  antibiotic  resis-
ance against  commonly  used  medications  in  Lagos,
igeria. Therefore,  it  can  be  suggested  that  antibi-
tic prescription  methods  in  urban  environments
imilar to  Lagos  affect  antibiotic-resistant  proﬁles
f S.  aureus  organisms.
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